INS and type 1 diabetes mellitus: The complex treatment regimen, despite advances in automated insulin delivery devices, also known as hybrid closed loop systems, requires up to several hundred additional decisions per day for an individual living with T1D or their carer, and is thought to have impacts of long-term quality of life (QoL) [4, 5].